Sign in
4

Changes in Ownership

Alzamend Neuro, Inc. Filed Acc 0001214659-25-010933

Director sold 69,137 shares at an average $2.95 ($203,821)

  • Director acquired 143,429 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

AULT MILTON C III · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-07-23 Conversion : show line 1 in the form +143,429 $2.32 $332,755 151,689 I
2025-07-23 Sale : show line 2 in the form −59,516 $2.95 $175,584 92,173 I
2025-07-24 Sale : show line 3 in the form −9,621 $2.93 $28,237 82,552 I
Open-market sales · 69,137 sh · avg $2.95 · $203,821

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-07-23 Conversion : show line 4 in the form Series B Convertible Preferred Stock −332.76 $1,000.00 $332,755 1,767.24 I
Loading xslF345X05/marketforms-70140.xml…